MEDICE focuses on four areas of compentence providing modern medications and helpful services in

• pediatric care, child and adolescent psychiatry (RX)
• nephrology, renal care (RX)
• self medication (OTC)
• general practice (OTX)

To emphasize our efforts MEDICE has been awarded

• as "best pharmacy partner" by the PharmaRundschau in 2009, 2010 and 2011
• with the "Golden Tablet" in 2011 by PharmaBarometer for its high reputation in pediatric care
• with the Marketing Price 2010 by the Marketing Club e.V.

General practice (OTX)

In general practice, MEDICE is focused on secondary care, i.e. prescription based medications paid by the patient. With its dedicated team, MEDICE is offering service and a portfolio of vitamin B preparations and orthomolecular medicine:

Medivitan® The re-vitalizing ready-to-use syringe is well established in general practice to cure vitamin deficiencies and to improve well-being and cognitive function.

Epidemiological and clinical studies have shown that every second  person aged > 65 years has an intracellular deficiency in vitamin B. For decades, administering B vitamins as an injection has been part of the standard therapeutic treatment in medical practice and every office. Medivitan® The re-vitalizing ready-to-use syringe is evidence-based (e.g. Lancet, 1995)

Medyn-forte® The oral vitamin B composition, indicated also to treat and prevent high homocysteine levels, a risk marker for vitamin deficiency related with secondary vascular and neuro-degenerative diseases.
MEDICE is the leading manufacturer of vitamin B injection treatments.

Omnival® orthomolecular offers a range of dietary food supplements indicated for special medical needs such as strengthening the immune system, bones and joints and other indications.

Self Medication (OTC)

MEDICE has a strong interest and position in serving the pharmacies:

• a broad portfolio of well-known brands
  (e.g. Meditonsin®, Soventol®, Dorithricin®, Tannacomp®)
• a strong team of specialized sales representatives covering 18000 pharmacies in Germany
• marketing & sales capabilites for brand and category management

Meditonsin® is one of the leading common cold remedies in Germany and neighboring countries.

Meditonsin® quickly helps when there is the threat of common colds, sore throats. This complex homeopathic method is taken with the first symptoms. Meditonsin® is individually dosable and due to its excellent tolerability it may be taken by all patients from 7-month-old babies to elderly.
For many years Meditonsin® has been a leading preparation in this indication, as a prescription by the doctor or self-medication by the patient.

Nephrology, renal care

MEDICE has a strong interest and position in serving patients with chronic renal insufficiency and on dialysis:

• a broad portfolio of well-established medications for special needs in renal care
• renal anemia (Abseamed®, FerMed®, Monofer®)
• phosphate management (Phosphonorm®, Calciumacetate Nefro®, CC-Nefro®)
• metablic acidosis (Nephrotrans®)
• electrolyte disturbances (Anti-Kalium®, Anti-Potasium®)
• special nutritional supplements (Addivit®, Nefrocarnit®)
• a team of well-trained sales representatives covering all dialysis centers and nephrologists in Germany and in selected European territories
• medical support for advice and pharmacovigilance
• medical research team for clinical studies

Pediatrics, Child and Adolescent Psychiatry

MEDICE has a strong interest and position in serving patients with Attention Deficit Hyperactivity Disorder (ADHD) and other CNS disturbances:

• the broadest portfolio of well-established and evidence-based medications of methylphenidate and amfetamine: 
• short-acting Medikinet® in 5, 10, 20mg dosage and
• long-acting Medikinet® XL (retard)  in 5, 10, 20, 30, 40 mg
• Medikinet® adult indicated for adult ADHS in 5, 10, 20, 30, 40 mg
• Attentin® 5mg snab tablets
• special services for specialized physicians and therapists (facilitating proper diagnosis and multi-modal treatment, involving child, parents, teachers and peers)
• a team of well-trained sales representatives covering all specialized pediatricians and child psychiatrists in Germany and in selected European territories
• medical support for advice and pharmacovigilance
• medical research team for clinical studies

We believe proper diagnosis of specialists and adequate multi-modal treatment gives affected children and adolescents the best basis to overcome and cope with their symptoms of hyperactivity, impulsiveness and co-morbidities.

The latest findings show that about 3-5 per cent of all schoolchildren aged between 6 and 15 years suffer from attention deficit hyperactivity disorder (ADHD). Boys are more frequently affected than girls. However, in Germany it is quite likely that not nearly all hyperactive children have been identified. These hyperactive children have problems concentrating. Unable to suppress the urge to do or say something, they interrupt classes by constant talking, distracted behaviour and their incapacity to sit quietly. They are often aggressive and as a result they are avoided by their schoolmates and other children. Scientists believe that hyperactive children suffer from a malfunction in the cerebral metabolism, particularly in the metabolism of the messenger substance dopamine. This is where treatment with methylphenidate plays a role.

Methylphenidate is a psychostimulant from the amphetamine group. It releases various messenger substances in the brain, thereby achieving an attenuating, modulating effect in hyperactive children. (In adults, on the other hand, performance is increased and compulsive narcoleptic attacks disappear.*)

Methylphenidate is thus prescribed as part of an overall therapeutic concept to combat attention deficit hyperactivity disorder (ADHD) in children (and also against compulsive bouts of sleepiness (narcolepsy) in adults*). It may only be taken under strict medical supervision.

Although methylphenidate cannot cure hyperactivity, it can alleviate it for periods of a few hours. The effect sets in after approx. 30-40 minutes and continues for about three to four hours.

In this phase children can participate normally in lessons. They are able to concentrate and learn. Even their writing improves and they perform better in intelligence tests.

top of page